Moore, A. S., Alonzo, T. A., Gerbing, R. B., Lange, B. J., Heerema, N. A., Franklin, J., . . . Meshinchi, S. (2013). BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group. Pediatr Blood Cancer.
Chicago Style CitationMoore, Andrew S., et al. "BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group." Pediatr Blood Cancer 2013.
Cita MLAMoore, Andrew S., et al. "BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group." Pediatr Blood Cancer 2013.